Skip to main content
Premium Trial:

Request an Annual Quote

Lisa Giles, Michael Kagnoff

GenMark Diagnostics has appointed Lisa Giles and Michael Kagnoff to its board of directors. It also said that Steve Worland has resigned from the board so he can focus on his role as president and CEO of Effector Therapeutics.

Giles is president and CEO of Giles & Associates Consultancy, a privately held management consulting firm. She also currently serves as CEO of Optivara, a software company owned by Giles & Associates. She is a former VP of strategy development for pharmaceuticals firm G.D. Searle. Kagnoff is a partner at law firm DLA Piper.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.